Does PEMBROLIZUMAB Cause Mucosal inflammation? 496 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 496 reports of Mucosal inflammation have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.6% of all adverse event reports for PEMBROLIZUMAB.
496
Reports of Mucosal inflammation with PEMBROLIZUMAB
0.6%
of all PEMBROLIZUMAB reports
63
Deaths
237
Hospitalizations
How Dangerous Is Mucosal inflammation From PEMBROLIZUMAB?
Of the 496 reports, 63 (12.7%) resulted in death, 237 (47.8%) required hospitalization, and 31 (6.3%) were considered life-threatening.
Is Mucosal inflammation Listed in the Official Label?
Yes, Mucosal inflammation is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which PEMBROLIZUMAB Alternatives Have Lower Mucosal inflammation Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G